Your shopping cart is currently empty

Zaloglanstat (ISC-27864) is a selective, orally active mPGES-1 inhibitor with an IC50 of 5 nM against human mPGES-1, demonstrating analgesic effects in osteoarthritis and inflammatory arthritis.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $165 | - | In Stock | |
| 5 mg | $413 | - | In Stock | |
| 10 mg | $689 | - | In Stock | |
| 25 mg | $1,450 | - | In Stock | |
| 50 mg | $1,960 | - | In Stock | |
| 100 mg | $2,630 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $455 | - | In Stock |
| Description | Zaloglanstat (ISC-27864) is a selective, orally active mPGES-1 inhibitor with an IC50 of 5 nM against human mPGES-1, demonstrating analgesic effects in osteoarthritis and inflammatory arthritis. |
| In vitro | Zaloglanstat exhibits selective inhibitory effects on both recombinant mPGES-1 activity and IL-1β in A549 cells, with IC50 values of 5 nM for both, while showing no significant inhibition on COX-1 and COX-2 (IC₅₀ >10 μM) [1]. In IL-1β-induced A549 cell and Homo sapiens synovial fibroblast models, Zaloglanstat can dose-dependently inhibit PGE₂ release, with an IC₅₀ value below 10 nM [1]. |
| Synonyms | ISC27864 |
| Molecular Weight | 452.86 |
| Formula | C21H20ClF3N4O2 |
| Cas No. | 1513852-12-4 |
| Smiles | CC(C)(C)C(=O)NCc1ccc(Cl)c(c1)-c1nn(-c2ccc(cc2)C(F)(F)F)c(=O)[nH]1 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 200 mg/mL (441.64 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+90% Corn Oil: 3.3 mg/mL (7.29 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.